Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy, non-smoking volunteers older than 18 years of age~Exclusion Criteria:~* history of gastrointestinal disease~* known infection~* previous eradication of Helicobacter pylori~* any prescription or over the counter antacid medication~* pregnant and lactating women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): * esomeprazole 20mg po once per day for 7 days~* 24hr pH study on day 7~* followed by washout for 7 days~* generic omeprazole 20mg po once per day for 7 days~* 24hr pH study on day 7
- 2 (Type: ACTIVE_COMPARATOR): * generic omeprazole 20mg po once per day for 7 days~* 24hr pH study on day 7~* followed by washout for 7 days~* esomeprazole 20mg po once per day for 7 days~* 24hr pH study on day 7

Based on this trial design, predict the completion outcome and termination type (if applicable).